MobileODT completes second institutional financing

MobileODT is pleased to announce it has successfully completed its second round of institutional financing. The announcement comes shortly before the launch of its AI-based cervical cancer screening test, VisualPap. OrbiMed Israel Advisors led the round, with Tara...

MobileODT Secures Series B Funding led by OrbiMed

Today, MobileODT announced it has raised an additional $6.825 million in a Series B fundraising round led by OrbiMed Advisors - a leading healthcare venture fund. Previous investors Tristel plc. also participated in the round. MobileODT has raised over $13 million to...

New Mobile Colposcope Outshining Standard

(June 12, 2017) Today, MobileODT announced the launch of its third generation mobile colposcope, the FDA-cleared EVA System. This improved device is 12% lighter, boasts improved lighting, and expands the user’s network and support system by serving as a secure...

Pin It on Pinterest